Position in PYXS
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$31,064
+$5,812 QoQ
Shares Held
21,277
-3.1% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#44
of 78 holders
Holding Since
Dec 2024
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in PYXS Over Time
Shares Held
Position Value (USD)
Derivatives in PYXS
reported options exposure · as of Mar 31, 2025CallValue
$116,522
CallShares
118,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Maia Wealth LLC holds $141,481 across 2 Biotechnology names. PYXS ranks #2 (22.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IBRX |
ImmunityBio, Inc.
|
14,396 | $110,417 | |
| 2 | PYXS |
Pyxis Oncology, Inc.
This page
|
21,277 | $31,064 |
All Filings in PYXS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31,064 | 21,277 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $25,252 | 21,959 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $116,522 | 118,900 | Call | Sole | 2025-05-12 | |
| 2024-12-31 | $185,484 | 118,900 | Call | Sole | 2025-02-05 | |
| No filing history on record for this holder in this stock. | ||||||